JPMorgan Chase & Co’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.69M | Buy |
|
|||||
|
2025
Q1 | $8.5M | Sell |
|
|||||
|
2024
Q4 | $15.9M | Sell |
|
|||||
|
2024
Q3 | $12.1M | Buy |
|
|||||
|
2024
Q2 | $12M | Buy |
|
|||||
|
2024
Q1 | $9.91M | Buy |
|
|||||
|
2023
Q4 | $231K | Sell |
|
|||||
|
2023
Q3 | $418K | Buy |
|
|||||
|
2023
Q2 | $677K | Buy |
|
|||||
|
2023
Q1 | $605K | Buy |
|
|||||
|
2022
Q4 | $660K | Buy |
|
|||||
|
2022
Q3 | $833K | Buy |
|
|||||
|
2022
Q2 | $706K | Buy |
|
|||||
|
2022
Q1 | $520K | Buy |
|
|||||
|
2021
Q4 | $464K | Buy |
|
|||||
|
2021
Q3 | $484K | Buy |
|
|||||
|
2021
Q2 | $531K | Buy |
|
|||||
|
2021
Q1 | $430K | Buy |
|
|||||
|
2020
Q4 | $262K | Buy |
|
|||||
|
2020
Q3 | $209K | Buy |
|
|||||
|
2020
Q2 | $96K | Sell |
|
|||||
|
2020
Q1 | $100K | Buy |
|